Welcome to our dedicated page for Gohealth news (Ticker: GOCO), a resource for investors and traders seeking the latest updates and insights on Gohealth stock.
GoHealth, Inc. reports developments in its Medicare-focused health insurance marketplace, where proprietary technology and licensed agents support consumer plan comparison and enrollment. News about GOCO commonly covers Medicare Advantage market conditions, Annual Enrollment Period activity, PlanFit technology, Special Needs Plans, retention initiatives, and the company’s efforts to match consumers with coverage suited to their needs.
Company updates also address quarterly and annual results, revenue mix, commission receivables, back-book durability, liquidity, cost discipline, automation and AI investments, and capital or governance actions. Recent coverage has emphasized a more disciplined Medicare Advantage posture, member quality, renewal economics, and strategic flexibility.
GoHealth (NASDAQ:GOCO) has initiated a voluntary prepackaged Chapter 11 process in Delaware to implement a restructuring plan backed by 100% of its lenders, over 60% of Class A shareholders, and over 99% of GoHealth Holdings interests.
The plan shifts ownership to lenders, reinstates preferred equity, pays trade creditors in full, provides cash to common shareholders, and aims for emergence before AEP 2026 while maintaining uninterrupted operations. GoHealth expects its Class A stock to be delisted from Nasdaq and potentially trade over the counter.
GoHealth (NASDAQ: GOCO) reported FY25 net revenue of $361.8M as Stonegate updated coverage following 4Q25, noting a continued Medicare Advantage pullback and carrier discipline. Management prioritized retention, member quality, liquidity, and protecting a ~$925M commissions receivable while investing selectively in SNPs, automation, and AI.
The update emphasizes durability over volume, cost discipline, and strategic optionality amid constrained enrollment conditions.
GoHealth (NASDAQ: GOCO) reported full-year 2025 results and outlined a disciplined strategy prioritizing consumer fit, renewal economics, cash preservation, and targeted AI investment. The company described an intentional pullback in Medicare Advantage enrollment to protect cohort quality and commission receivables while maintaining SNP leadership.
GoHealth emphasized improved year-over-year retention, investments in proprietary AI and automation, strategic flexibility, and readiness for broker consolidation to position for scale as market conditions stabilize.
GoHealth (NASDAQ: GOCO) reported a challenging 3Q25 with net revenues of $34.2M, down ~71.0% y/y as the company intentionally pulled back Medicare Advantage volume and experienced reduced non-agency activity.
Other revenue grew as GoHealth Protect scaled. Results were depressed by significant non-cash impairment charges, while management emphasized liquidity preservation, platform efficiency, retention-first actions, and disciplined execution through the 2025 AEP. Liquidity at quarter end was $32.1M and strategic flexibility improved via a superpriority term loan and covenant relief.
GoHealth (NASDAQ: GOCO) reported third-quarter 2025 results on November 13, 2025, describing a deliberate pullback in Medicare Advantage volume to prioritize member quality, retention, and platform efficiency. The company said it conserved liquidity, reduced fixed cost, and preserved core retention and agent-enablement capabilities while maintaining leadership in Special Needs Plans.
GoHealth also stated it secured a superpriority term loan facility, received covenant relief, and refreshed its board to retain strategic flexibility for potential integration and consolidation as the Medicare Advantage market rationalizes.
GoHealth (NASDAQ: GOCO) announced it will release third quarter 2025 financial results on the morning of November 13, 2025. CEO Vijay Kotte and CFO Brendan Shanahan will host a conference call and live audio webcast at 8:00 a.m. ET the same day to discuss the results.
The live audio webcast will be available on GoHealth's Investor Relations website at https://investors.gohealth.com/, and a replay will be posted for on-demand listening shortly after the call.
GoHealth (NASDAQ: GOCO) said it is deploying proprietary tools to help Medicare consumers through the 2026 Annual Enrollment Period (Oct 15–Dec 7) amid significant market disruption. The company highlighted its PlanFit reviews and PlanGPT AI assistant to improve plan comparisons, support licensed agents, and cut call times.
GoHealth cited industry headwinds—about 2 million Medicare Advantage plan exits and 10 million plan degradations—plus risks of smaller networks, reduced supplemental benefits, and higher copays. The company reported nearly 30,000 PlanFit confirmations last AEP and said its AI tools cut average call time by 10 minutes in 2024.
GoHealth Inc. (NASDAQ: GOCO) reported challenging Q2 2025 results, with net revenues declining 11.2% year-over-year to $94.0M. The company experienced significant decreases in partner revenue (-44.4%) and non-agency revenue (-79.4%), partially offset by growth in GoHealth Protect segment.
The company secured $115M in new and rolled-up loans and amended its credit agreement to waive near-term principal payments. Q2 resulted in a $115.9M net loss, including a $53M intangible asset impairment charge, though adjusted EBITDA showed slight improvement to -$11.3M year-over-year. Cost efficiency improved with marketing and consumer care expenses declining 26% and 33% respectively.
GoHealth (NASDAQ: GOCO) has announced significant strategic capital and governance actions to enhance its financial flexibility. The company secured a new $80 million senior secured superpriority term loan facility plus $35 million in roll-up loans to support working capital ahead of the Medicare annual enrollment period.
Key actions include amending the existing credit agreement to waive principal payments through 2026, creating a $250 million debt basket capacity for transformative transactions, and issuing 4.7 million shares of Class A common stock to lenders. The company also appointed three new directors while accepting resignations from three existing board members.
GoHealth (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, has scheduled an announcement regarding strategic capital and governance actions along with its Q2 2025 financial results for August 7, 2025.
CEO Vijay Kotte and CFO Brendan Shanahan will host a conference call and webcast at 8:00 a.m. ET to discuss these developments. The presentation will be accessible through GoHealth's Investor Relations website, with a replay available after the event.